Legal Opinion
Fujisawa Pharmaceutical Company, Ltd., and Fujisawa Usa, Inc. v. John K. Kapoor
Court of Appeals for the Seventh Circuit
Decided June 16, 1997No. 96-3133PublishedCited by 115 opinions
1Opinion of the Court
POSNER, Chief Judge.
Between 1984 and 1989, Fujisawa Pharmaceutical Company, a large manufacturer of drugs, purchased stock in Lyphomed, Inc., a manufacturer of both proprietary and generic drugs that was controlled by its principal shareholder and executive, John Kapoor. By 1986, Fujisawa had displaced Kapoor as Ly-phomed’s largest shareholder, owning 30 percent of its shares; and in 1990 Fujisawa merged Lyphomed into a wholly owned subsidiary of Fujisawa that is, along with Fujisa-wa itself, a plaintiff in this case (we shall refer to both plaintiffs, collectively, as Fujisa: wa). By this…
2Cases cited28 opinions
- H. J. Inc. v. Northwestern Bell Telephone Co.Supreme Court of the United States · 1989
- United States v. TurketteSupreme Court of the United States · 1981
- Lampf, Pleva, Lipkind, Prupis & Petigrow v. GilbertsonSupreme Court of the United States · 1991
- Agency Holding Corp. v. Malley-Duff & Associates, Inc.Supreme Court of the United States · 1987
- Joseph F. Cada v. Baxter Healthcare CorporationCourt of Appeals for the Seventh Circuit · 1991
23 more not listed; retrieve them via the Exa API.
3Cited by115 opinions
- Merck & Co. v. ReynoldsSupreme Court of the United States · 2010
- Shawn Owens v. William E. Boyd, Warden, Western Illinois Correctional CenterCourt of Appeals for the Seventh Circuit · 2000
- Galvan v. NorbergCourt of Appeals for the Seventh Circuit · 2012
- Steginsky v. Xcelera Inc.Court of Appeals for the Second Circuit · 2014
- Tello v. Dean Witter Reynolds, Inc.Court of Appeals for the Eleventh Circuit · 2005
110 more not listed; retrieve them via the Exa API.